Novel evidence associates higher plasma &#945;-synuclein levels and cognitive impairment in Parkinson's disease.

Aarsland, Dag; Rajkumar, Anto P; Hye, Abdul

Novel evidence associates higher plasma α-synuclein levels and cognitive impairment in Parkinson's disease.

Aarsland, Dag; Rajkumar, Anto P; Hye, Abdul.

Afiliação

Aarsland D; Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Rajkumar AP; Mental Health of Older Adults and Dementia Clinical Academic Group, South London and Maudsley NHS Foundation Trust, London, UK.
Hye A; Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

J Neurol Neurosurg Psychiatry ; 88(10): 808, 2017 10.

Article em En | MEDLINE | ID: mdl-28607120

Assuntos

Doença de Parkinson; alfa-Sinucleína; Peptídeos beta-Amiloides; Disfunção Cognitiva; Demência; Humanos

Palavras-chave

Dementia; cognition; parkinson's disease

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Alfa-Sinucleína Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: J Neurol Neurosurg Psychiatry Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google